One Dose of Acoziborole Led to Cure of ‘Sleeping Sickness’ Across Disease Stages
A single dose of oral acoziborole proved to be efficacious and safe for adults and adolescents with gambiense human African trypanosomiasis (HAT), also known as “sleeping sickness,” suggesting its promise in interrupting transmission, a single-arm phase II/III trial showed. Over 18 months of follow-up, the treatment success rate was 95.2% in those with late-stage disease […]